Business Context and Reporting Period
Aterian, Inc., formerly Mohawk Group Holdings, Inc., filed this Form 8-K on April 2, 2021 regarding matters voted on at its April 1, 2021 Special Meeting of Stockholders. The company’s common stock traded under the symbol MWK on Nasdaq. The filing is not a periodic financial report and does not provide operating results for a reporting period.
Meeting Participation and Key Financial Matters
- 15,533,054 shares, representing 52.62% of the common stock outstanding as of the March 11, 2021 record date, were represented at the meeting.
- Stockholders approved the issuance of common stock associated with the Senior Secured Note Due 2022 and Senior Secured Note Due 2023.
- Stockholders approved issuance of up to 469,931 shares upon exercise of a February 2, 2021 warrant.
- Stockholders approved issuance of up to 1,016,912 shares under the February 2, 2021 Asset Purchase Agreement and related consulting agreements.
- Stockholders approved issuance of up to 750,000 shares upon exercise of a February 9, 2021 warrant.
- Stockholders approved potential issuance of securities under a refinancing of the Senior Secured Notes, including a potential warrant.
- Stockholders approved up to $100.0 million of securities in one or more non-public offerings, with discounts of up to 20% below the market price, subject to applicable Nasdaq rules.
- No revenue, profit, cash flow, margin, debt balance, or liquidity figures are provided in this filing. The filing identifies the Senior Secured Notes as debt instruments but does not state their principal amounts or terms.
Material Changes and Voting Results
Proposals 1 through 6 required approval excluding 1,387,759 shares issued to Healing Solutions, LLC and 980,000 shares issued to High Trail Investments SA, LLC. Each of Proposals 1 through 6 was approved overwhelmingly, with approximately 13.13 million votes in favor and fewer than 25,000 votes against each proposal. Proposal 7 was approved with 15,026,382 votes in favor, 496,734 against, and 9,938 abstentions.
Proposal 8, authorizing an adjournment if necessary to solicit additional proxies, was also approved, but no adjournment was required because Proposals 1 through 7 passed.
Outlook, Risks, Contingencies, and Unusual Items
- The approvals permit substantial potential equity issuance and securities offerings, which could result in dilution to existing stockholders.
- The authorized non-public offerings may be completed at discounts of up to 20% below the market price.
- Potential refinancing may involve additional senior secured debt and warrants; the filing does not confirm that a refinancing occurred.
- The filing references prior share issuances, warrants, debt instruments, and an asset acquisition but provides no operating guidance or management outlook.
Investor Verification Items
- Verify the current status, principal amounts, maturities, interest rates, and collateral arrangements of the Senior Secured Notes Due 2022 and Due 2023.
- Determine whether the approved securities offerings, refinancing, warrants, or additional shares were subsequently issued.
- Assess the potential dilution from the approved share issuances and warrants.
- Review the February 2, 2021 Asset Purchase Agreement and related consulting agreements, including consideration and contingent share obligations.
- Confirm the company’s subsequent name and ticker changes from Mohawk Group Holdings, Inc. and MWK to Aterian, Inc. and the applicable trading symbol.